Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.
Cole B Hirschfeld, Leslee J Shaw, Michelle C Williams, Ryan Lahey, Todd C Villines, Sharmila Dorbala, Andrew D Choi, Nishant R Shah, David A Bluemke, Daniel S Berman, Ron Blankstein, Maros Ferencik, Jagat Narula, David Winchester, Eli Malkovskiy, Benjamin Goebel, Michael J Randazzo, Juan Lopez-Mattei, Purvi Parwani, Joao V Vitola Show all
JACC Cardiovasc Imaging | Published : 2021
OBJECTIVES: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. BACKGROUND: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. METHODS: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions ..View full abstract